ACP

Acuta Capital Partners Portfolio holdings

AUM $71.6M
This Quarter Return
+22.28%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$507M
AUM Growth
+$507M
Cap. Flow
-$5.68M
Cap. Flow %
-1.12%
Top 10 Hldgs %
74.82%
Holding
77
New
18
Increased
7
Reduced
8
Closed
10

Top Buys

1
KDMN
Kadmon Holdings, Inc.
KDMN
$12.4M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
$9.73M
3
SRPT icon
Sarepta Therapeutics
SRPT
$7.93M
4
VKTX icon
Viking Therapeutics
VKTX
$7.12M
5
OBSV
ObsEva SA Ordinary Shares
OBSV
$6.42M

Top Sells

1
IMMU
Immunomedics Inc
IMMU
$26M
2
ASND icon
Ascendis Pharma
ASND
$15.5M
3
ARWR icon
Arrowhead Research
ARWR
$9.95M
4
AVXS
AveXis, Inc. Common Stock
AVXS
$7.42M
5
TNDM icon
Tandem Diabetes Care
TNDM
$6.68M

Sector Composition

1 Healthcare 75.18%
2 Communication Services 0%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
FENC icon
26
Fennec Pharmaceuticals
FENC
$247M
$2.61M 0.46% 250,000 – –
LRMR icon
27
Larimar Therapeutics
LRMR
$310M
$2.56M 0.46% +250,000 New +$2.56M
ACER
28
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
$2.36M 0.42% +109,270 New +$2.36M
DNTH icon
29
Dianthus Therapeutics
DNTH
$759M
$2.3M 0.41% +170,000 New +$2.3M
TSRO
30
DELISTED
TESARO, Inc.
TSRO
$2.22M 0.4% +50,000 New +$2.22M
VCEL icon
31
Vericel Corp
VCEL
$1.83B
$1.84M 0.33% +190,055 New +$1.84M
KZR icon
32
Kezar Life Sciences
KZR
$28.9M
$1.73M 0.31% +100,000 New +$1.73M
FTSV
33
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$1.17M 0.21% +73,000 New +$1.17M
ALIM
34
DELISTED
Alimera Sciences, Inc.
ALIM
$953K 0.17% 974,318 – –
VIVE
35
DELISTED
VIVEVE MED INC
VIVE
$728K 0.13% 267,500 -417,715 -61% -$1.14M
OTLK icon
36
Outlook Therapeutics
OTLK
$37.8M
$25K ﹤0.01% 29,082 – –
ANIP icon
37
ANI Pharmaceuticals
ANIP
$2.03B
– – 0 – –
AXDX
38
DELISTED
Accelerate Diagnostics
AXDX
– – 0 – –
CRSP icon
39
CRISPR Therapeutics
CRSP
$4.71B
– – 0 – –
DB icon
40
Deutsche Bank
DB
$67.7B
– – 0 – –
EDIT icon
41
Editas Medicine
EDIT
$231M
– – 0 – –
EEM icon
42
iShares MSCI Emerging Markets ETF
EEM
$19B
– – 0 – –
ESPR icon
43
Esperion Therapeutics
ESPR
$448M
– – 0 – –
FXI icon
44
iShares China Large-Cap ETF
FXI
$6.65B
– – 0 – –
GKOS icon
45
Glaukos
GKOS
$5.5B
– – 0 – –
REGN icon
46
Regeneron Pharmaceuticals
REGN
$61.5B
– – 0 – –
RMTI icon
47
Rockwell Medical
RMTI
$58.9M
– – 0 – –
SGMO icon
48
Sangamo Therapeutics
SGMO
$157M
– – 0 – –
STAA icon
49
STAAR Surgical
STAA
$1.36B
– – 0 – –
TEVA icon
50
Teva Pharmaceuticals
TEVA
$21.1B
– – 0 – –
1
2
3 4